Voyageur Pharmaceuticals Ltd
XTSX:VM
Voyageur Pharmaceuticals Ltd
XTSX:VM
Price:
0.145
CAD
Market Cap:
CA$25.9m
Balance Sheet
Balance Sheet Decomposition
Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd
Balance Sheet Decomposition is not available for
Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd
Balance Sheet
Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd
Currency: CAD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | Nov-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+14%
|
0
-25%
|
0
-11%
|
0
-44%
|
1
+693%
|
1
+23%
|
1
+46%
|
2
+27%
|
1
-21%
|
3
+101%
|
2
-18%
|
2
+3%
|
3
+20%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
-50%
|
0
+685%
|
0
-88%
|
0
+318%
|
1
+2 366%
|
1
-22%
|
1
+14%
|
1
+14%
|
1
-32%
|
1
-5%
|
1
+15%
|
2
+195%
|
|
| Equity | |||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
6
|
8
|
9
|
9
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
4
|
6
|
8
|
9
|
11
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
+16%
|
0
-18%
|
0
-55%
|
0
-2%
|
1
+737%
|
0
N/A
|
1
N/A
|
1
+46%
|
0
-59%
|
2
+522%
|
1
-23%
|
1
-2%
|
0
-69%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+14%
|
0
-25%
|
0
-11%
|
0
-44%
|
1
+693%
|
1
+23%
|
1
+46%
|
2
+27%
|
1
-21%
|
3
+101%
|
2
-18%
|
2
+3%
|
3
+20%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
2
|
2
|
2
|
39
|
54
|
66
|
71
|
102
|
115
|
133
|
139
|
|
Switch to:
Switch to:
See Also
Discover More
